|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/195 | |
| A61K 31/197 | |||
| A61K 31/522 | |||
| A61K 31/4985 | |||
| A61K 31/53 | |||
| A61P 25/00 | |||
| A61P 25/02 |
| (11) | Number of the document | 1536782 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03787957.4 |
| Date of filing the European patent application | 2003-08-04 | |
| (97) | Date of publication of the European application | 2005-06-08 |
| (45) | Date of publication and mention of the grant of the patent | 2007-04-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2003/003476 |
| Date | 2003-08-04 |
| (87) | Number | WO 2004/016259 |
| Date | 2004-02-26 |
| (30) | Number | Date | Country code |
| 0219024 | 2002-08-15 | GB |
| (72) |
FIELD, Mark, John, GB
WILLIAMS, Richard, Griffith, GB
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, GB |
| (54) | SYNERGISTIC COMBINATION OF AN ALPHA-2-DELTA LIGAND AND A PDEV INHIBITOR FOR USE IN THE TREATMENT OF PAIN |
| SYNERGISTIC COMBINATION OF AN ALPHA-2-DELTA LIGAND AND A PDEV INHIBITOR FOR USE IN THE TREATMENT OF PAIN |